Summary of all studies containing PUBCHEM ID 1060
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR000016 | ST000017 | Rat HCR/LCR Stamina Study | Animal | Rattus norvegicus | PYRUVATE [Data] |
PR000046 | ST000048 | Metabolomic & lipidomic profiles in response to exogenous insulin & GLP-1 infusions during prolonged fasting (GCMS) | Animal | Mirounga angustirostris | pyruvic acid [Data] |
PR000054 | ST000057 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (GCMS) | Animal | Mus musculus | pyruvic acid [Data] |
PR000082 | ST000090 | Caloric Restriction vs drugs | Animal | Mus musculus | PYRUVATE [Data] |
PR000142 | ST000164 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Animal | Mus musculus | Pyruvate [Data] |
PR000153 | ST000178 | T cell metabolism during graft-versus-host disease (CAB 307)-PART I | Animal | Mus musculus | pyruvate [Data] |
PR000158 | ST000185 | Fetal Lambs vascular graft Normal v Shunt LECs | Animal | Ovis aries | pyruvate [Data] |
PR000169 | ST000215 | Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO GTT 1 mice | Animal | Mus musculus | Pyruvate_123 [Data] |
PR000169 | ST000215 | Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO GTT 1 mice | Animal | Mus musculus | Pyruvate_123_13C_1 [Data] |
PR000169 | ST000215 | Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO GTT 1 mice | Animal | Mus musculus | Pyruvate_123_13C_2 [Data] |
PR000169 | ST000215 | Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO GTT 1 mice | Animal | Mus musculus | Pyruvate_123_13C_3 [Data] |
PR000219 | ST000143 | Metabolic analysis of Normal Mouse Lung Fiboblasts with/without TGFbeta treatment (Part 1) | Animal | Mus musculus | Pyruvate [Data] |
PR000219 | ST000183 | Metabolic analysis of Parp1 ko/wt Saline & Bleo Mouse Lung Fiboblasts and Human IPF & Normal Lung Fiboblasts (Part 3) | Animal | Mus musculus | pyruvate [Data] |
PR000219 | ST000275 | Metabolic analysis of Parp1 ko/wt Saline & Bleo Mouse Lung Fiboblasts and Human IPF & Normal Lung Fiboblasts (Part 2) | Animal | Mus musculus | pyruvate [Data] |
PR000252 | ST000313 | Muscle Clock knock out mice metabolic changes (iMSBmal1-Exp1) | Animal | Mus musculus | Pyruvic acid [Data] |
PR000349 | ST000451 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Animal | Mus musculus | Pyruvate [Data] |
PR000349 | ST000452 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Animal | Mus musculus | Pyruvate [Data] |
PR000375 | ST000498 | Cocaine administration and withdrawal (part I) | Animal | Rattus norvegicus | Pyruvate [Data] |
PR000461 | ST000658 | Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice (part IV) | Animal | Mus musculus | pyruvic acid [Data] |
PR000461 | ST000660 | Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice (part I) | Animal | Mus musculus | pyruvic acid [Data] |
PR000521 | ST000724 | Red squirrels age related changes | Animal | Tamiasciurus hudsonicus | PYRUVIC ACID (M-H)- [Data] |
PR000669 | ST000979 | Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Part I) | Animal | Felis catus | pyruvic acid [Data] |
PR000075 | ST000084 | Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation | Animal cells | Mus musculus | pyruvic acid [Data] |
PR000414 | ST000692 | Metabolites produced by strains associated with inflammation | Bacteria | Treponema pectinovorum | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000989 | ST001439 | Metabolites in contents of small intestine in wild type and DAOG181R/G181R mice | Bacteria | Mus musculus | Pyruvic acid [Data] |
PR001252 | ST001966 | NMR Hydrophilic Metabolomic Analysis of Bacterial Resistance Pathways using Multivalent Antimicrobials with Challenged and Unchallenged Wild Type and Mutated Gram Positive Bacteria | Bacteria | Bacillus cereus | Pyruvate [Data] |
PR001394 | ST002187 | Interplay of CodY and CcpA in regulating central metabolism and biofilm formation in S. aureus | Bacteria | Staphylococcus aureus | Pyruvate [Data] |
PR001467 | ST002287 | Enhanced systemic commensal E. coli immunogenicity through minor alteration of the metabolic profile | Bacteria | Escherichia coli | Pyruvic acid [Data] |
PR000075 | ST000085 | Salmonella Modulates Metabolism during Growth under Conditions that Induce Expression of Virulence Genes | Bacterial cells | Salmonella typhimurium | pyruvic acid [Data] |
PR000105 | ST000116 | Comparative metabolomics analysis of the key metabolic nodes in propionic acid synthesis in Propionibacterium acidipropionici | Bacterial cells | Acidipropionibacterium acidipropionici | Pyruvate [Data] |
PR000106 | ST000118 | Metabolomics analysis of multiple metabolic functions in the YjgF/YER057c/UK114 (Rid) protein family GCMS (part 2) | Bacterial cells | Salmonella enterica;Escherichia coli | pyruvic acid [Data] |
PR000199 | ST000247 | Determining the metabolic profile of wildtype and nos mutant Staphylococcus aureus grown in media lacking glucose using targeted LC/MS | Bacterial cells | Staphylococcus aureus | Pyruvate [Data] |
PR000248 | ST000309 | Metabolome of three Vancomycin-intermediate Staphylococcus aureus (VISA) mutants compared with the parent strain MM66 | Bacterial cells | Staphylococcus aureus | pyruvic acid [Data] |
PR000280 | ST000351 | Determining the metabolic profile of wildtype, lrgAB, and atlA mutant Steptococcus mutans grown aerobically and anaerobically | Bacterial cells | Streptococcus mutans | Pyruvate [Data] |
PR000358 | ST000466 | Streptococcus mutans organic acids/amino acid profiles, effect of oxidative stress; pilot | Bacterial cells | Streptococcus mutans | Pyruvate [Data] |
PR000316 | ST000404 | Role of HVCN1 in B cell malignancies | Cells | Homo sapiens | pyruvic acid [Data] |
PR000626 | ST000900 | Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting function | Cells | Escherichia coli | pyruvic acid [Data] |
PR000664 | ST000968 | Impact of thiamine metabolites and spent medium from Chlorella sorokiniana on metabolism in the green algae Auxenochlorella prototheciodes (part I) | Cultured cells | Auxenochlorella protothecoides | pyruvic acid [Data] |
PR000664 | ST000969 | Impact of thiamine metabolites and spent medium from Chlorella sorokiniana on metabolism in the green algae Auxenochlorella prototheciodes (part II) | Cultured cells | Auxenochlorella protothecoides | pyruvic acid [Data] |
PR000758 | ST001133 | Downregulation of CENPF epigenetically remodels prostate cancer cells and alters cellular metabolism | Cultured cells | Homo sapiens | pyruvic acid [Data] |
PR000782 | ST001170 | Timecourse on MCF-7 cells treated with different concentration of doxorubicin | Cultured cells | Homo sapiens | Pyruvic acid [Data] |
PR000867 | ST001282 | Role of Hi1a in mitochondrial metabolic rewiring in M1 Macrophages | Cultured cells | Mus musculus | pyruvic acid [Data] |
PR000867 | ST001283 | Nitric Oxide (NO) effect on mitochondrial metabolic rewiring in M1 Macrophages | Cultured cells | Mus musculus | pyruvic acid [Data] |
PR001035 | ST001610 | Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours | Cultured cells | Homo sapiens | Pyruvic acid [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | pyruvate M0 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | pyruvate M1 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | pyruvate M2 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | pyruvate M3 [Data] |
PR001132 | ST001779 | Untargeted Metabolomics analysis of A549 treated with 0.5 mM extracellular ATP and 10 ng/ml TGF-beta | Cultured cells | Homo sapiens | Pyruvic acid [Data] |
PR001212 | ST001921 | An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection | Cultured cells | Homo sapiens | pyruvic acid [Data] |
PR001262 | ST001986 | Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells | Cultured cells | Mus musculus | pyruvate [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | Pyruvic acid-m0 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | Pyruvic acid-m1 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | Pyruvic acid-m2 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | Pyruvic acid-m3 [Data] |
PR001340 | ST002115 | LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001418 | ST002220 | Catabolism of branched-chain amino acids (BCAAs) in renal cells HK2 and 786-O | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001418 | ST002224 | Intracellular metabolic profile of renal cells cultured in Plasmax | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001418 | ST002225 | Time sensitive contribution of the BCAA catabolism to the TCA cycle carbons in HK2, 786-O, OS-RC-2 and RFX-631 | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001418 | ST002226 | Exometabolomics of HK2, 786-O cells cultured in Plasmax media | Cultured cells | Homo sapiens | pyruvate [Data] |
PR001424 | ST002234 | A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis | Cultured cells | Homo sapiens | Pyruvic acid [Data] |
PR001431 | ST002242 | Hypoxia promotes osteogenesis via regulating the acetyl-CoA-mediated mito-nuclear communication. | Cultured cells | Mus musculus | pyruvate [Data] |
PR001488 | ST002322 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mus musculus | pyruvate [Data] |
PR001524 | ST002371 | High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages | Cultured cells | Mus musculus | pyruvate [Data] |
PR001580 | ST002450 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 1 of 3) | Cultured cells | Mus musculus | Pyruvic acid [Data] |
PR001636 | ST002540 | Deriving Schwann Cells from hPSCs Enables Disease Modeling and Drug Discovery for Diabetic Peripheral Neuropathy | Cultured cells | Homo sapiens | pyruvic acid [Data] |
PR001679 | ST002709 | FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer | Cultured cells | NCCFH1, UOK262, UTFHC1 | pyruvate [Data] |
PR001686 | ST002719 | Comparison of metabolic of A549 cells before and after Gossypol acetate (GAA) treatment | Cultured cells | Homo sapiens | Pyruvic acid [Data] |
PR001869 | ST002999 | Metabolomics and glucose and glutamine labeled isotope tracing analysis in murine lung adenocarcinoma cells in the context of normal or active NRF2 pathway as well as HDAC and glutaminase inhibitor treatment. | Cultured cells | Mus musculus | Pyruvate [Data] |
PR001941 | ST003123 | OMM1.3 uveal melanoma cells fed with [U-13C6] glucose and treated with Fasnall for 4 h | Cultured cells | Homo sapiens | Pyruvate C12 PARENT [Data] |
PR001941 | ST003123 | OMM1.3 uveal melanoma cells fed with [U-13C6] glucose and treated with Fasnall for 4 h | Cultured cells | Homo sapiens | Pyruvate C13-label-1 [Data] |
PR001941 | ST003123 | OMM1.3 uveal melanoma cells fed with [U-13C6] glucose and treated with Fasnall for 4 h | Cultured cells | Homo sapiens | Pyruvate C13-label-2 [Data] |
PR001941 | ST003123 | OMM1.3 uveal melanoma cells fed with [U-13C6] glucose and treated with Fasnall for 4 h | Cultured cells | Homo sapiens | Pyruvate C13-label-3 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Pyruvate C12 PARENT [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Pyruvate C13-label-1 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Pyruvate C13-label-2 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Pyruvate C13-label-3 [Data] |
PR000381 | ST000508 | Metabolic Profiling of Date Palm Fruits | Date palm fruit | Phoenix dactylifera | pyruvate [Data] |
PR000381 | ST000867 | Metabolic Profiling of Date Palm Fruits (part II) | Date palm fruit | Phoenix dactylifera | pyruvate [Data] |
PR001158 | ST001834 | A metabolomics comparison of plant-based meat and grass-fed meat indicates large nutritional differences despite comparable nutrition facts labels | Food item | - | Pyruvic acid [Data] |
PR000002 | ST000002 | Intestinal Samples II pre/post transplantation | Human | Homo sapiens | pyruvate [Data] |
PR000008 | ST000009 | Mixed meal tolerance | Human | Homo sapiens | PYRUVATE [Data] |
PR000040 | ST000041 | High PUFA diet in humans | Human | Homo sapiens | PYRUVATE [Data] |
PR000041 | ST000042 | BALF Control vs ALI by RPLC-MS | Human | Homo sapiens | PYRUVATE [Data] |
PR000043 | ST000044 | Pilot experiment looking for the existence of certain molecules in pancreatic cancer cells | Human | Homo sapiens | PYRUVATE [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyruvicacid [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyruvicacid-1.0565577 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyruvicacid-1.1454303 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyruvicacid-1.2166147 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyruvicacid-1.2594115 [Data] |
PR000045 | ST000046 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Human | Homo sapiens | Pyruvicacid-2.9096313 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid-1.0026177 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid-1.127027 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid-1.2604657 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid-2.0019042 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid-3.0151846 [Data] |
PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Pyruvicacid-3.3105016 [Data] |
PR000049 | ST000051 | Fetal metabolomic signature of exposure to iAs during pregnancy | Human | Homo sapiens | Pyruvate [Data] |
PR000058 | ST000061 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: GC-TOF MS analyis of subcutaneous and visceral adipose tissue samples | Human | Homo sapiens | pyruvic acid [Data] |
PR000058 | ST000065 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: GC-TOF MS analyis of serum samples | Human | Homo sapiens | pyruvic acid [Data] |
PR000059 | ST000062 | Biomarkers for Depression in Human Plasma in a Population Sample | Human | Homo sapiens | pyruvic acid [Data] |
PR000084 | ST000092 | A statistical analysis of the effects of urease pre-treatment on the measurement of the urinary metabolome by gas chromatographymass spectrometry | Human | Homo sapiens | pyruvic acid [Data] |
PR000085 | ST000093 | Metabolomics Analysis of Frontal Fibrosing Alopecia | Human | Homo sapiens | pyruvate [Data] |
PR000097 | ST000105 | SCOR Metabolomics | Human | Homo sapiens | PYRUVATE [Data] |
PR000098 | ST000106 | IWMS Study 1:Weight comparison of obese and lean patients | Human | Homo sapiens | PYRUVATE [Data] |
PR000122 | ST000137 | Metabolomics in sarcoidosis | Human | Homo sapiens | Pyruvate [Data] |
PR000129 | ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | Homo sapiens | Pyruvate_123 [Data] |
PR000129 | ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | Homo sapiens | Pyruvate_123_13C_1 [Data] |
PR000129 | ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | Homo sapiens | Pyruvate_123_13C_2 [Data] |
PR000129 | ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | Homo sapiens | Pyruvate_123_13C_3 [Data] |
PR000131 | ST000150 | Association of Metabolic Profile and Microbiome in Chronic Pressure Ulcer Wounds | Human | Homo sapiens | Pyruvate [Data] |
PR000144 | ST000166 | Cardiac Resynchronization Therapy Induces Adaptive Metabolic Transitions in the Metabolomic Profile of Heart Failure | Human | Homo sapiens | Pyruvic acid [Data] |
PR000154 | ST000276 | IDH1 and Glioma knockdown idh1 | Human | Homo sapiens | pyruvate [Data] |
PR000186 | ST000230 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Human | Homo sapiens | Pyruvic acid [Data] |
PR000202 | ST000250 | The Role of Obesity and Adipocytes in Immune Activation on Antiretroviral Therapy | Human | Homo sapiens | Pyruvate [Data] |
PR000222 | ST000279 | Viral Effect on Metabolism (part II) | Human | Homo sapiens | pyruvate [Data] |
PR000224 | ST000282 | Pilot Study 13C flux effects when RhoC or RhoA perturbed (13C BCs) | Human | Homo sapiens | Pyruvate_123 [Data] |
PR000224 | ST000282 | Pilot Study 13C flux effects when RhoC or RhoA perturbed (13C BCs) | Human | Homo sapiens | Pyruvate_123_13C_1 [Data] |
PR000224 | ST000282 | Pilot Study 13C flux effects when RhoC or RhoA perturbed (13C BCs) | Human | Homo sapiens | Pyruvate_123_13C_2 [Data] |
PR000224 | ST000282 | Pilot Study 13C flux effects when RhoC or RhoA perturbed (13C BCs) | Human | Homo sapiens | Pyruvate_123_13C_3 [Data] |
PR000226 | ST000284 | Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling | Human | Homo sapiens | Pyruvate [Data] |
PR000233 | ST000291 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | Pyruvate_1 [Data] |
PR000233 | ST000291 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | Pyruvate_2 [Data] |
PR000234 | ST000293 | Vitamin B6 Effects on one-carbon metabolism | Human | Homo sapiens | Pyruvate [Data] |
PR000268 | ST000336 | Targeted LC/MS of urine from boys with DMD and controls | Human | Homo sapiens | Pyruvate [Data] |
PR000269 | ST000337 | Metabolomics Approach to Allograft Assessment in Liver Transplantation | Human | Homo sapiens | Pyruvate [Data] |
PR000299 | ST000381 | Urinary Metabolites in IC/PBS Diagnosis (part I) | Human | Homo sapiens | pyruvic acid [Data] |
PR000309 | ST000396 | Lung Cancer Plasma Discovery | Human | Homo sapiens | pyruvic acid [Data] |
PR000348 | ST000450 | Metabolic features of chronic fatigue syndrome | Human | Homo sapiens | Pyruvic acid [Data] |
PR000445 | ST000608 | Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies | Human | Homo sapiens | pyruvic acid [Data] |
PR000451 | ST000617 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Human | Homo sapiens | Pyruvic acid [Data] |
PR000488 | ST000689 | Influence of Noxa knockdown on cell metabolism | Human | Homo sapiens | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000489 | ST000690 | Human oral keratinocytes growth and proliferation based on culture medium volume | Human | Homo sapiens | PYRUVIC ACID [Data] |
PR000510 | ST000713 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm | Human | Homo sapiens | PYRUVIC ACID (M-H)- [Data] |
PR000518 | ST000721 | Metabolomic Profiles of Recovery from Traumatic Brain Injury | Human | Homo sapiens | PYRUVIC ACID (M-H)- [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000536 | ST000743 | Metabolomics of bariatric weight loss | Human | Homo sapiens | PYRUVIC ACID (M-H)- [Data] |
PR000667 | ST001842 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part I) | Human | Homo sapiens | pyruvic acid [Data] |
PR000749 | ST001118 | Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature | Human | Homo sapiens | pyruvic acid [Data] |
PR000756 | ST001131 | Presentation of different serum metabolites in trauma patients versus healthy volunteers. | Human | Homo sapiens | pyruvic acid [Data] |
PR000862 | ST001284 | Pseudoexfoliation Aqueous Humor Metabolites from Veterans Affairs Patients NMR (part-II) | Human | Homo sapiens | Pyruvate [Data] |
PR000863 | ST001285 | POAG and Control Aqueous Humor IROA Metabolites from Veterans Affairs Patients NMR (part-II) | Human | Homo sapiens | Pyruvate [Data] |
PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | pyruvate [Data] |
PR000960 | ST001400 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Human | Homo sapiens | pyruvate [Data] |
PR000960 | ST001516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Human | Homo sapiens | pyruvate [Data] |
PR000960 | ST001517 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Human | Homo sapiens | pyruvate [Data] |
PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | pyruvate [Data] |
PR000968 | ST001412 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Human | Homo sapiens | pyruvate [Data] |
PR000974 | ST001420 | Metabolomic analysis of patients with recurrent angina | Human | Homo sapiens | Pyruvic acid [Data] |
PR001022 | ST001515 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Human | Homo sapiens | pyruvate [Data] |
PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | pyruvate [Data] |
PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | pyruvate [Data] |
PR001053 | ST001719 | Metabolomics Analysis of Philadelphia Cohort - Update (part-I) | Human | Homo sapiens | Pyruvic acid [Data] |
PR001053 | ST001720 | Metabolomics Analysis of ACTG Cohort -Update (part-II) | Human | Homo sapiens | Pyruvic acid [Data] |
PR001072 | ST001669 | Serum metabolome of Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Pyruvic acid [Data] |
PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | pyruvate [Data] |
PR001133 | ST001780 | Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise | Human | Homo sapiens | Pyruvic acid [Data] |
PR001133 | ST001789 | Acute metabolomic changes of plasma in response to endurance exercise | Human | Homo sapiens | Pyruvic acid [Data] |
PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | pyruvate [Data] |
PR001213 | ST001922 | Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages | Human | Homo sapiens | Pyruvic acid [Data] |
PR001222 | ST001933 | Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patients | Human | Homo sapiens | Pyruvic acid [Data] |
PR001226 | ST001937 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Human | Homo sapiens | pyruvic acid-1 [Data] |
PR001226 | ST001937 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Human | Homo sapiens | pyruvic acid-2 [Data] |
PR001226 | ST001937 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Human | Homo sapiens | pyruvic acid-3 [Data] |
PR001226 | ST001937 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Human | Homo sapiens | pyruvic acid-4 [Data] |
PR001228 | ST001940 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Human | Homo sapiens | pyruvate [Data] |
PR001269 | ST002000 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 1) | Human | Homo sapiens | pyruvic acid [Data] |
PR001281 | ST002017 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Human | Homo sapiens | pyruvate [Data] |
PR001281 | ST002018 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Human | Homo sapiens | pyruvate [Data] |
PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | pyruvate [Data] |
PR001282 | ST002020 | TIPs Metabolomics (urine) | Human | Homo sapiens | pyruvate [Data] |
PR001287 | ST002026 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/GC) | Human | Homo sapiens | pyruvic acid [Data] |
PR001339 | ST002113 | Metabolomic analyses redefine the biological classification of pancreatic cancer: From clinical stage to metabolic subtype | Human | Homo sapiens | Pyruvate [Data] |
PR001398 | ST002194 | Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation | Human | Homo sapiens | Pyruvic Acid [Data] |
PR001432 | ST002244 | Metabolomics analysis of Friedreich's ataxia (FRDA) (part I) | Human | Homo sapiens | Pyruvic acid [Data] |
PR001500 | ST002337 | Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Pyruvic acid [Data] |
PR001606 | ST002484 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: primary metabolism | Human | Homo sapiens | pyruvic acid [Data] |
PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | pyruvate [Data] |
PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | pyruvate [Data] |
PR001762 | ST002819 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Human | Homo sapiens | pyruvate [Data] |
PR001762 | ST002820 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Human | Homo sapiens | pyruvate [Data] |
PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | pyruvate [Data] |
PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | pyruvate [Data] |
PR001863 | ST002993 | Identifying subgroups of childhood obesity by using multiplatform metabotyping | Human | Homo sapiens | Pyruvic acid [Data] |
PR000219 | ST000828 | Metabolic analysis of Parp1 ko/wt Saline & Bleo Mouse Lung Fiboblasts and Human IPF & Normal Lung Fiboblasts 3 | HUMAN | Homo sapiens | PYRUVIC ACID [Data] |
PR000494 | ST000697 | Cytokines correlation with metabolomic profiling of psoriatic and normal skin | HUMAN | Homo sapiens | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000554 | ST000768 | Metabolites of human neurons and stem cells (siNeuron metabolomics) | HUMAN | Homo sapiens | PYRUVIC ACID (M-H)- [Data] |
PR000579 | ST000814 | Hormones & Cognition/Aging/Placebo | HUMAN | Homo sapiens | PYRUVIC ACID [Data] |
PR000599 | ST000841 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | HUMAN | Homo sapiens | PYRUVIC ACID (M-H)- [Data] |
PR000599 | ST000842 | Muscle and plasma before and after exercise | HUMAN | Homo sapiens | PYRUVIC ACID (M-H)- [Data] |
PR000009 | ST000010 | Lung Cancer Cells 4 | Human cells | Homo sapiens | PYRUVATE [Data] |
PR000010 | ST000011 | African Metabolomics | Human cells | Homo sapiens | PYRUVATE [Data] |
PR000055 | ST000058 | Metabolite changes associated with methionine stress sensitivity of cancer (GC TOF MS analysis) | Human cells | Homo sapiens | pyruvic acid [Data] |
PR000079 | ST000087 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: GC-TOF MS analysis | Human cells | Homo sapiens | pyruvic acid [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C0[+13CD3 QDA]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C0[+QDA adduct]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C0[+QDA adduct+Na]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C1[+13CD3 QDA]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C1[+QDA adduct]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C1[+QDA adduct+Na]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C2[+13CD3 QDA]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C2[+QDA adduct]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C3[+13CD3 QDA]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C3[+QDA adduct]+ [Data] |
PR000127 | ST000142 | H1299 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C3[+QDA adduct+Na]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C0[+13CD3 QDA]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C0[+QDA adduct]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C0[+QDA adduct+Na]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C1[+13CD3 QDA]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C1[+QDA adduct]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C2[+13CD3 QDA]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C2[+QDA adduct]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C3[+13CD3 QDA]+ [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | Pyruvate-13C3[+QDA adduct]+ [Data] |
PR000129 | ST000144 | Primary T Cell Baseline (Donor 5) - II | Human cells | Homo sapiens | Pyruvate_123 [Data] |
PR000129 | ST000144 | Primary T Cell Baseline (Donor 5) - II | Human cells | Homo sapiens | Pyruvate_123_13C_1 [Data] |
PR000129 | ST000144 | Primary T Cell Baseline (Donor 5) - II | Human cells | Homo sapiens | Pyruvate_123_13C_2 [Data] |
PR000129 | ST000144 | Primary T Cell Baseline (Donor 5) - II | Human cells | Homo sapiens | Pyruvate_123_13C_3 [Data] |
PR000129 | ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human cells | Homo sapiens | Pyruvate_123 [Data] |
PR000129 | ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human cells | Homo sapiens | Pyruvate_123_13C_1 [Data] |
PR000129 | ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human cells | Homo sapiens | Pyruvate_123_13C_2 [Data] |
PR000129 | ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human cells | Homo sapiens | Pyruvate_123_13C_3 [Data] |
PR000129 | ST000147 | 13C targeted metabolomics | Human cells | Homo sapiens | Pyruvate_123 [Data] |
PR000129 | ST000147 | 13C targeted metabolomics | Human cells | Homo sapiens | Pyruvate_123_13C_1 [Data] |
PR000129 | ST000147 | 13C targeted metabolomics | Human cells | Homo sapiens | Pyruvate_123_13C_2 [Data] |
PR000129 | ST000147 | 13C targeted metabolomics | Human cells | Homo sapiens | Pyruvate_123_13C_3 [Data] |
PR000588 | ST000826 | CHEAR Christiani NMR | Human Chord Blood Serum | Homo sapiens | Pyruvate [Data] |
PR000362 | ST000474 | Metabolomic testing of a putative MDH inhibitor (targeted) | Human leukemia cells | Homo sapiens | Pyruvate [Data] |
PR000625 | ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human serum | Homo sapiens | pyruvate [Data] |
PR000519 | ST000722 | Metabolomics of Diapause in Aedes albopictus | Insect | Aedes albopictus | PYRUVIC ACID (M-H)- [Data] |
PR000741 | ST001110 | Investigating link between metabolism and circadian rhythm in Drosophila melanogaster | Insect | Drosophila melanogaster | pyruvic acid [Data] |
PR000727 | ST001088 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-I) | Invertebrate | Metacarcinus magister | pyruvic acid [Data] |
PR000697 | ST001041 | Development of a weaned pig model of enterotoxigenic E.coli-induced environmental enteropathy | Mammal | Sus scrofa | pyruvic acid [Data] |
PR000704 | ST001051 | High Salt Diet versus Low Salt Diet in rats | Mammal | Rattus norvegicus | pyruvic acid [Data] |
PR000721 | ST001078 | Multi-platform metabolomics data from Ndufs4-/- skeletal muscles (part-V) | Mammal | Mus musculus | Pyruvic acid [Data] |
PR000737 | ST001101 | Identification of potential sepsis biomarkers in burn injury conditions. | Mammal | Mus musculus | pyruvic acid [Data] |
PR000764 | ST001143 | Microbial depletion and ozone exposure - Lung tissue (part I) | Mammal | Mus musculus | pyruvate [Data] |
PR000764 | ST001144 | Microbial depletion and ozone exposure - serum (part II) | Mammal | Mus musculus | pyruvate [Data] |
PR000773 | ST001154 | A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium | Mammal | Mus musculus | pyruvic acid [Data] |
PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | pyruvate [Data] |
PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | pyruvate [Data] |
PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | pyruvate [Data] |
PR000999 | ST001467 | Metabolites changes related to glucose-mediated energy production in chemotheraphy-induced cachexia | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001005 | ST001523 | The effect of fasting and sirtuin overexpression on serum metabolome. | Mammal | Mus musculus | pyruvic acid [Data] |
PR001013 | ST001495 | Effects of Synbiotic Administration on Fecal Microbiome and Metabolomic Profiles of Dogs receiving Antibiotics | Mammal | Canis lupus familiaris | pyruvic acid [Data] |
PR001027 | ST001526 | Mitochondrial health is enhanced in rats with higher vs. lower intrinsic exercise capacity and extended lifespan | Mammal | Rattus norvegicus | pyruvic acid [Data] |
PR001031 | ST001606 | Aromatic amino acid metabolism by the anaerobic gut bacterium Clostridium sporogenes | Mammal | Mus musculus | pyruvic acid [Data] |
PR001037 | ST001614 | NMR metabolomics analysis of ricin-induced and fasting hypoglycemia (part-I) | Mammal | Mus musculus | Pyruvate [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001051 | ST001643 | Deletion of the diabetes candidate gene Slc16a13 in mice | Mammal | Mus musculus | pyruvic acid [Data] |
PR001071 | ST001668 | D-Allulose effects on hepatic metabolomics profile in rodents | Mammal | Rattus norvegicus | Pyruvic acid [Data] |
PR001074 | ST001683 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Mammal | Mus musculus | PYRUVIC ACID [Data] |
PR001089 | ST001701 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Liver) part-III | Mammal | Mus musculus | pyruvic acid [Data] |
PR001089 | ST001702 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Heart) part-IV | Mammal | Mus musculus | pyruvic acid [Data] |
PR001089 | ST001703 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Brain) part-V | Mammal | Mus musculus | pyruvic acid [Data] |
PR001118 | ST001745 | Metabolomic profiling of the rat hippocampus across developmental ages and after learning | Mammal | Rattus norvegicus | pyruvate [Data] |
PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | pyruvate [Data] |
PR001143 | ST001809 | The Metabolic Benefits of Short Cycles of Very Low Caloric Intake are Dependent on Diet Composition in Middle-Aged Mice | Mammal | Mus musculus | pyruvic acid [Data] |
PR001164 | ST001847 | Standardized gnotobiotic mouse model for NMR based phenotyping | Mammal | Mus musculus | Pyruvate [Data] |
PR001170 | ST001855 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 1) | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | pyruvate [Data] |
PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | pyruvate [Data] |
PR001253 | ST001967 | Analytical methodology for a metabolome atlas of goat’s plasma, milk and feces using 1H-NMR and UHPLC-HRMS:NMR/plasma | Mammal | Capra hircus | Pyruvic acid [Data] |
PR001366 | ST002153 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001373 | ST002160 | Global metabolomics analysis of neutrophils isolated from tumor | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001416 | ST002216 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received metronidazole using high-resolution, high-performance LC-MS/MS analysis. | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001416 | ST002217 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received 1% choline supplementation or control diet using high-resolution, high-performance LC-MS/MS analysis. | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001419 | ST002228 | Estrogen receptor a deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 2) | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001460 | ST002280 | Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyruvic acid_13C_1 [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyruvic acid_13C_2 [Data] |
PR001580 | ST002451 | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) | Mammal | Mus musculus | Pyruvic acid_13C_3 [Data] |
PR001585 | ST002457 | Mouse kidney metabolomics (Whole kidney) | Mammal | Mus musculus | Pyruvate [Data] |
PR001626 | ST002524 | In situ microwave fixation provides an instantaneous snapshot of the brain metabolome - Part 1 | Mammal | Mus musculus | pyruvic acid [Data] |
PR001626 | ST002525 | In situ microwave fixation provides an instantaneous snapshot of the brain metabolome - Part 2 | Mammal | Mus musculus | pyruvic acid [Data] |
PR001648 | ST002556 | Blood metabolomics and impacted cellular mechanisms during transition into lactation in dairy cows that develop metritis | Mammal | Bos taurus | pyruvic acid [Data] |
PR001678 | ST002708 | Levels of central carbon metabolites in choroid plexus as part of natural diurnal variation | Mammal | Mus musculus | pyruvate [Data] |
PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | pyruvate [Data] |
PR001719 | ST002758 | Metabolic responses of normal rat kidneys to a high salt intake (Plasma) | Mammal | Rattus norvegicus | Pyruvic acid [Data] |
PR001719 | ST002759 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Mammal | Rattus norvegicus | Pyruvic acid [Data] |
PR001719 | ST002760 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Mammal | Rattus norvegicus | Pyruvic acid [Data] |
PR001719 | ST002761 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Mammal | Rattus norvegicus | Pyruvic acid [Data] |
PR001748 | ST002801 | Investigation of metabolism in hypertrophic cardiomyopathy | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001761 | ST002814 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy | Mammal | Mus musculus | pyruvate [Data] |
PR001761 | ST002878 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. | Mammal | Mus musculus | pyruvate [Data] |
PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | pyruvate [Data] |
PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | pyruvate [Data] |
PR001786 | ST002852 | MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer | Mammal | Mus musculus | pyruvate [Data] |
PR001864 | ST002994 | Integrating uterine microbiome and metabolome to advance the understanding of the uterine environment in dairy cows with metritis | Mammal | Bos taurus | pyruvic acid [Data] |
PR001897 | ST003047 | Defective mitochondria remodelling in B cells leads to an aged immune response | Mammal | Mus musculus | Pyruvic acid [Data] |
PR001941 | ST003152 | Metabolomics analysis of murine xenograft tumors derived from human breast cancer cell line MCF7 1 h after isotopic glucose bolus | Mammal | Mus musculus | Pyruvate C12 PARENT [Data] |
PR001941 | ST003152 | Metabolomics analysis of murine xenograft tumors derived from human breast cancer cell line MCF7 1 h after isotopic glucose bolus | Mammal | Mus musculus | Pyruvate C13-label-1 [Data] |
PR001941 | ST003152 | Metabolomics analysis of murine xenograft tumors derived from human breast cancer cell line MCF7 1 h after isotopic glucose bolus | Mammal | Mus musculus | Pyruvate C13-label-2 [Data] |
PR001941 | ST003152 | Metabolomics analysis of murine xenograft tumors derived from human breast cancer cell line MCF7 1 h after isotopic glucose bolus | Mammal | Mus musculus | Pyruvate C13-label-3 [Data] |
PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | pyruvate [Data] |
PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | pyruvate [Data] |
PR000417 | ST000569 | Effect of minimal and complex media on the metabolite profiles | Microorganisms | Saccharomyces cerevisiae | pyruvate [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | PYRUVIC ACID [Data] |
PR000148 | ST000701 | Differences in metabolism in mouse embryonic fibroblasts (control vs SCF-beta-TrCP knockout) | Mouse | Mus musculus | PYRUVIC ACID - 0.9791428 [Data] |
PR000165 | ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Mus musculus | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000499 | ST000702 | NIH 3T3 fibroblast cells with Ceftriaxone Treatment | Mouse | Mus musculus | PYRUVATE (M-H)- [Data] |
PR000538 | ST000745 | Metabolomics of mice inoculated with human microbiota | Mouse | Mus musculus | PYRUVIC ACID [Data] |
PR000538 | ST000746 | Metabolomics of mice inoculated with human stool (part II) | Mouse | Mus musculus | PYRUVIC ACID [Data] |
PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | PYRUVIC ACID (M-H)- [Data] |
PR000509 | ST000840 | Diabetic heart adrenergic signaling and metabolism (STZ & Isoproterenol, High Fat) - part II | MOUSE | Mus musculus | PYRUVIC ACID [Data] |
PR000594 | ST000833 | Influence of murine norovirus on cell metabolism | MOUSE | Mus musculus | PYRUVIC ACID [Data] |
PR000669 | ST000981 | Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Part II) | Other | Felis catus | pyruvic acid [Data] |
PR000895 | ST001318 | Atg32-mediated mitophagy promotes heat stress tolerance in Saccharomyces cerevisiae by sustaining spermidine and nitric oxide levels | Other | Saccharomyces cerevisiae | pyruvic acid [Data] |
PR000006 | ST000007 | Rice Infection Study | Plant | Oryza sativa Japonica Group | pyruvate [Data] |
PR000692 | ST001034 | PAMP-triggered changes in the exometabolome of Arabidopsis suspension cells | Plant | Arabidopsis thaliana | pyruvic acid [Data] |
PR001002 | ST001478 | NMR spectroscopy analysis reveals altered metabolic homeostasis in Arabidopsis seedlings treated with a cytokinesis inhibitor | Plant | Arabidopsis thaliana | Pyruvate [Data] |
PR001234 | ST001947 | Metabolite profiling of shoots of juvenile maize plants | Plant | Zea mays | Pyruvic acid [Data] |
PR001494 | ST002330 | Early-stage responses to Plasmodiophora brassicae at the metabolome levels in clubroot resistant and susceptible oilseed Brassica napus | Plant | Brassica napus | Pyruvic acid [Data] |
PR001609 | ST002492 | Composition of raw plant-based food items | Plant | Malus domestica/Musa acuminata/Solanum lycopersicum/Lactuca sativa/Fragaria x ananassa/Daucus carota/Prunus persica/Allium cepa/Spinacia oleracea/Capsicum annuum/Zea mays/Allium sativum/Ocimum basilicum/Solanum tuberosum/Glycine max/Phaseolus vulgaris/Olea europaea/Cicer arietinum/Beta vulgaris/Pyrus communis | pyruvate [Data] |
PR001609 | ST002493 | Composition of raw plant-based food items Pilot Study | Plant | Malus domestica/Solanum lycopersicum/Lactuca sativa/Fragaria x ananassa/Allium sativum/Ocimum basilicum | pyruvic acid [Data] |
PR000540 | ST000749 | Rat amniotic fluid metabolomics | Rat | Rattus norvegicus | PYRUVIC ACID (M-H)- [Data] |
PR000540 | ST000750 | Rat amniotic fluid metabolomics (part II) | Rat | Rattus norvegicus | PYRUVIC ACID (M-H)- [Data] |
PR000545 | ST000756 | Metabolomics of cilia and modulation of renal microcirculation | Rat | Rattus norvegicus | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | PYRUVATE (CAS# 127-17-3); (M-H)- [Data] |
PR000548 | ST000759 | Age and exercise effect on metabolomics in rats | Rat | Rattus norvegicus | PYRUVIC ACID (M-H)- [Data] |
PR000593 | ST000832 | Rat Retinal Detachment Metabolomics Timecourse | RAT | Rattus norvegicus | PYRUVIC ACID [Data] |
PR000961 | ST001401 | Steady-state metabolomics time course of Saccharomyces cerevisiae mitochondrial fatty acid synthesis (mtFAS) mutants | Yeast | Saccharomyces cerevisiae | Pyruvic acid [Data] |
PR001241 | ST001954 | A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia | Yeast | Saccharomyces cerevisiae | pyruvate [Data] |